BMO Capital lowered the firm’s price target on CSX (CSX) to $35 from $36 but keeps an Outperform rating on the shares. The company’s Q1 results were below expectations as the network continues to be affected by several transitory challenges, which are expected to persist for the bulk of 2025 albeit at a moderating pace, the analyst tells investors in a research note. BMO adds however that the stock represents an opportunity for patient value investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSX:
- CSX price target lowered to $30 from $31 at RBC Capital
- Positive Outlook for CSX: Buy Rating Amid Temporary Challenges and Strategic Turnaround
- CSX price target lowered to $31 from $32 at Bernstein
- CSX price target lowered to $34 from $36 at Stephens
- CSX price target lowered to $33 from $34 at Stifel